{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:13:40Z","timestamp":1790957620027,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Asia"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jacasi.2023.02.006","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T17:44:20Z","timestamp":1683049460000},"page":"446-454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"P2","title":["Clinical Outcomes of Calcium-Channel Blocker vs Beta-Blocker"],"prefix":"10.1016","volume":"3","author":[{"given":"Moo Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song Lin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao Yan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Rak","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacasi.2023.02.006_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jacasi.2023.02.006_bib2","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O'Gara","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2023.02.006_bib3","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2023.02.006_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2023.02.006_bib5","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2023.02.006_bib6","doi-asserted-by":"crossref","first-page":"767","DOI":"10.4070\/kcj.2018.0251","article-title":"Coronary artery vasospasm","volume":"48","author":"Song","year":"2018","journal-title":"Korean Circ J"},{"key":"10.1016\/j.jacasi.2023.02.006_bib7","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1253\/circj.CJ-66-0098","article-title":"Guidelines for diagnosis and treatment of patients with vasospastic angina","volume":"78","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.jacasi.2023.02.006_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1253\/circj.69.39","article-title":"Role of vasospasm in acute coronary syndrome: insights from ergonovine stress echocardiography","volume":"69","author":"Kim","year":"2005","journal-title":"Circ J"},{"key":"10.1016\/j.jacasi.2023.02.006_bib9","article-title":"Clinical outcomes of vasospastic angina patients presenting with acute coronary syndrome","volume":"5","author":"Cho","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacasi.2023.02.006_bib10","first-page":"1593","article-title":"Outcomes of nonagenarians with acute myocardial infarction with or without coronary intervention","volume":"11","author":"Oh","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jacasi.2023.02.006_bib11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10557-016-6682-1","article-title":"Beta-blockers and calcium channel blockers: first line agents","volume":"30","author":"Pascual","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacasi.2023.02.006_bib12","doi-asserted-by":"crossref","first-page":"28a","DOI":"10.1016\/0002-9149(94)90271-2","article-title":"Usefulness of amlodipine for angina pectoris","volume":"73","author":"Taylor","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacasi.2023.02.006_bib13","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(04)16980-8","article-title":"Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial","volume":"364","author":"Poole-Wilson","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacasi.2023.02.006_bib14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM198608143150704","article-title":"Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial","volume":"315","author":"Gibson","year":"1986","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacasi.2023.02.006_bib15","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0140-6736(00)02262-5","article-title":"Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT)","volume":"355","author":"Boden","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jacasi.2023.02.006_bib16","article-title":"Benefit of vasodilating beta-blockers in patients with acute myocardial infarction after percutaneous coronary intervention: nationwide multicenter cohort study","volume":"6","author":"Chung","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacasi.2023.02.006_bib17","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM198104023041401","article-title":"Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction","volume":"304","year":"1981","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacasi.2023.02.006_bib18","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.1982.03320370021023","article-title":"A\u00a0randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results","volume":"247","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.jacasi.2023.02.006_bib19","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"Beta Blockade after myocardial infarction: systematic review and meta regression analysis","volume":"318","author":"Freemantle","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.jacasi.2023.02.006_bib20","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacasi.2023.02.006_bib21","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jacasi.2023.02.006_bib22","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.amjmed.2014.05.032","article-title":"Clinical outcomes with beta-blockers for myocardial infarction: a meta-analysis of randomized trials","volume":"127","author":"Bangalore","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.jacasi.2023.02.006_bib23","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jcin.2013.12.206","article-title":"Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"7","author":"Yang","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacasi.2023.02.006_bib24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/ehjcvp\/pvaa029","article-title":"Effect of beta-blocker therapy in patients with or without left ventricular systolic dysfunction after acute myocardial infarction","volume":"7","author":"Joo","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacasi.2023.02.006_bib25","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/FJC.0000000000001221","article-title":"Long-term beta-blocker therapy after myocardial infarction without heart failure in the reperfusion era-systemic review and meta-analysis","volume":"79","author":"Kim","year":"2022","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacasi.2023.02.006_bib26","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.amjcard.2004.01.006","article-title":"Comparison of the effects of beta blockers and calcium antagonists on cardiovascular events after acute myocardial infarction in Japanese subjects","volume":"93","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacasi.2023.02.006_bib27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40265-017-0691-7","article-title":"Drug therapy for stable angina pectoris","volume":"77","author":"Rousan","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.jacasi.2023.02.006_bib28","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.jacc.2017.03.578","article-title":"\u03b2-Blockers and mortality after acute myocardial infarction in patients without heart failure or ventricular dysfunction","volume":"69","author":"Dondo","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["JACC: Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374723000868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374723000868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:58:33Z","timestamp":1757411913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772374723000868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2772374723000868"],"URL":"https:\/\/doi.org\/10.1016\/j.jacasi.2023.02.006","relation":{},"ISSN":["2772-3747"],"issn-type":[{"value":"2772-3747","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcomes of Calcium-Channel Blocker vs Beta-Blocker","name":"articletitle","label":"Article Title"},{"value":"JACC: Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacasi.2023.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}